Binosto
Payments companies reported to CMS as associated with Binosto. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Binosto, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Binosto
These are the largest totals companies reported as associated with Binosto. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jacqueline Kernaghan | Springfield, PA | Medical | $240.00 |
| Joseph Lane | New York, NY | Orthopaedic Surgery | $107.94 |
| Jae Eun Yoo | New York, NY | Adult Health (Nurse Practitioner) | $107.94 |
| Martin Grajower | Bronx, NY | Endocrinology, Diabetes & Metabolism | $100.03 |
| Toni Otello | Bronx, NY | Adult Health (Nurse Practitioner) | $100.03 |
| Polina Liss | New York, NY | Internal Medicine | $72.35 |
| Harry Kaplan | Baltimore, MD | Internal Medicine | $66.59 |
| Minisha Sood | New York, NY | Endocrinology, Diabetes & Metabolism | $66.13 |
| Caroline Messer | Mount Kisco, NY | Endocrinology, Diabetes & Metabolism | $66.13 |
| Yun Feng | New York, NY | Endocrinology, Diabetes & Metabolism | $59.69 |
Prescribed Binosto?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.